Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues.

[1]  T. Bilfinger,et al.  Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. , 1998, Journal of cardiovascular pharmacology.

[2]  G. Stefano.  Autoimmunovascular regulation: morphine and ancondamide and ancondamide stimulated nitric oxide release , 1998, Journal of Neuroimmunology.

[3]  E. Ellis,et al.  Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock , 1997, Nature.

[4]  H. Li,et al.  Expression of endothelin-1 and constitutional nitric oxide synthase messenger RNA in saphenous vein endothelial cells exposed to arterial flow shear stress. , 1997, The Annals of thoracic surgery.

[5]  D. Kendall,et al.  Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. , 1997, European journal of pharmacology.

[6]  D. Deutsch,et al.  Production and physiological actions of anandamide in the vasculature of the rat kidney. , 1997, The Journal of clinical investigation.

[7]  A. Kustka,et al.  Morphine- and anadamide-stimulated nitric oxide production inhibits presynaptic dopamine release , 1997, Brain Research.

[8]  T. Bilfinger,et al.  Cryopreserved veins in myocardial revascularization: possible mechanism for their increased failure. , 1997, The Annals of thoracic surgery.

[9]  D. Deutsch,et al.  Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. , 1997, Biochemical pharmacology.

[10]  L. Petrocellis,et al.  Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. , 1997, Biochemical and biophysical research communications.

[11]  Stephen P. H. Alexander,et al.  An endogenous cannabinoid as an endothelium-derived vasorelaxant. , 1996, Biochemical and biophysical research communications.

[12]  G. Stefano,et al.  Inhibition of the Met-enkephalin-induced K+ current in B-cluster neurons of Aplysia by nitric oxide donor , 1996, Brain Research.

[13]  M. Goligorsky,et al.  Cannabinoid Receptors Are Coupled to Nitric Oxide Release in Invertebrate Immunocytes, Microglia, and Human Monocytes* , 1996, The Journal of Biological Chemistry.

[14]  J. Beauvillain,et al.  Purification, Sequence Analysis, and Cellular Localization of a Prodynorphin-derived Peptide Related to the α-Neo-endorphin in the Rhynchobdellid Leech Theromyzon tessulatum* , 1996, The Journal of Biological Chemistry.

[15]  E. Ellis,et al.  Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. , 1995, The American journal of physiology.

[16]  A. Howlett,et al.  Rat brain cannabinoid receptors are N-linked glycosylated proteins. , 1995, Life sciences.

[17]  M. Kaghad,et al.  An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.

[18]  D. Deutsch,et al.  Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. , 1993, Biochemical pharmacology.

[19]  S. Moncada,et al.  Nitric oxide synthase activities in human myocardium , 1993, The Lancet.

[20]  F. Evans,et al.  Cannabinoids: The Separation of Central from Peripheral Effects on a Structural Basis , 1991, Planta medica.

[21]  R Fischmeister,et al.  Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  H. C. Hartzell,et al.  Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells , 1986, Nature.

[23]  M. Lewis,et al.  Effects of 8-bromo-cyclic GMP on contraction and on inotropic response of ferret cardiac muscle. , 1991, Journal of molecular and cellular cardiology.